On this episode of Stock Movers:
- European pharmaceutical stocks may be active after the US government said Tuesday that it negotiated a 71% discount of the list price of Novo Nordisk's drugs Ozempic and Wegovy for patients in Medicare. 
- Pernod Ricard is dipping after JPMorgan is taking a generally cautious stance on European consumer staples heading into 2026, with higher unemployment and low consumer confidence expected to see delivery again weighted to second half of the year, driven by fiscal packages and easier comparatives. 
- Next is one of the companies on the frontline in today's UK budget as companies watch for a possible patchwork of levies.

On this episode of Stock Movers: - European pharmaceutical stocks may be active after the US government said Tuesday that it negotiated a 71% discount of the list price of Novo Nordisk's drugs Ozempic and Wegovy for patients in Medicare.&nbsp; - Pernod Ricard is dipping after JPMorgan is taking a generally cautious stance on European consumer staples heading into 2026, with higher unemployment and low consumer confidence expected to see delivery again weighted to second half of the year, driven by fiscal packages and easier comparatives. - Next is one of the companies on the frontline in today's UK budget as companies watch for a possible patchwork of levies.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Novo Nordisk's Discount, Pernod Ricard Dips, Next Jitters

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/75c4ae79-5756-4dfc-b559-b3a10096e33b/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week: 

- Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it’s finally benefiting from a boom in AI spending. Intel’s stock soared in New York trading Friday, reaching a record high for the first time since August 2000. The single-day percentage gain was the largest since October 1987, and it brought Intel’s year-to-date increase to 124%.

- Lululemon (LULU) fell the most in more than seven months after naming a Nike veteran as chief executive officer, underscoring investor skepticism that the yogawear brand can recapture the growth of past years. The shares dropped as much as 12% on Thursday in in New York trading, the most since September 2025. The stock had fallen more than 21% this year as of Wednesday’s close.

- Psychedelic-linked stocks, like Compass Pathways (CMPS) surged this week after President Donald Trump signed an executive order last weekend to expedite research and access. On Monday, US-traded shares of Compass Pathways Plc spiked as much as 53% while AtaiBeckley Inc. surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% — touching its highest intraday level since July 2023.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week: - Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it&rsquo;s finally benefiting from a boom in AI spending. Intel&rsquo;s stock soared in New York trading Friday, reaching a record high for the first time since August 2000. The single-day percentage gain was the largest since October 1987, and it brought Intel&rsquo;s year-to-date increase to 124%. - Lululemon (LULU) fell the most in more than seven months after naming a Nike veteran as chief executive officer, underscoring investor skepticism that the yogawear brand can recapture the growth of past years. The shares dropped as much as 12% on Thursday in in New York trading, the most since September 2025. The stock had fallen more than 21% this year as of Wednesday&rsquo;s close. - Psychedelic-linked stocks, like Compass Pathways (CMPS) surged this week after President Donald Trump signed an executive order last weekend to expedite research and access. On Monday, US-traded shares of Compass Pathways Plc spiked as much as 53% while AtaiBeckley Inc. surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% &mdash; touching its highest intraday level since July 2023.

Weekly Roundup: Intel's Big Rally, Lululemon Falls Sharply, Psychedelic-Tied Stocks Soar

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/86879ecb-f733-4c70-a321-b436016a387c/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers: 

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it’s finally benefiting from a boom in AI spending. The upbeat outlook suggests that Chief Executive Officer Lip-Bu Tan is making progress on a once-improbable turnaround. After lining up major investments in Intel last year — helping to strengthen the company’s balance sheet — he’s now delivering on a promise to improve operations. Intel’s stock soared as much as 28% to $85.22 in New York trading Friday, reaching a record high for the first time since August 2000. It had gained 81% this year heading into the report.

- Alphabet (GOOGL) will invest $10 billion in Anthropic PBC, with another $30 billion potentially to follow, strengthening the relationship between two companies that are at once partners and rivals in the race to build artificial intelligence. Anthropic said that Google is committing to invest $10 billion now in cash at a $350 billion valuation, the same amount it was valued at in a funding round in February, not including the recent money raised. The Alphabet Inc.-owned company will invest another $30 billion if Anthropic hits performance targets, the startup said Friday, and support a significant expansion of Anthropic’s computing capacity. Shares of Google were up on Friday after the news.

- HCA Healthcare (HCA) tumbled Friday after it opted against raising its yearly profit and sales guidance even though first quarter profit beat analysts’ views, meaning it could foresee challenges later in the year. The hospital operator reaffirmed its yearly adjusted earnings forecast of $29.10 to $31.50 a share. It reported first-quarter adjusted earnings of $7.15 a share, compared to the average analyst estimate of $7.10 a share. Adjusted earnings before interest, taxes, depreciation and amortization missed estimates.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. - Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it&rsquo;s finally benefiting from a boom in AI spending. The upbeat outlook suggests that Chief Executive Officer Lip-Bu Tan is making progress on a once-improbable turnaround. After lining up major investments in Intel last year &mdash; helping to strengthen the company&rsquo;s balance sheet &mdash; he&rsquo;s now delivering on a promise to improve operations. Intel&rsquo;s stock soared as much as 28% to $85.22 in New York trading Friday, reaching a record high for the first time since August 2000. It had gained 81% this year heading into the report. - Alphabet (GOOGL) will invest $10 billion in Anthropic PBC, with another $30 billion potentially to follow, strengthening the relationship between two companies that are at once partners and rivals in the race to build artificial intelligence. Anthropic said that Google is committing to invest $10 billion now in cash at a $350 billion valuation, the same amount it was valued at in a funding round in February, not including the recent money raised. The Alphabet Inc.-owned company will invest another $30 billion if Anthropic hits performance targets, the startup said Friday, and support a significant expansion of Anthropic&rsquo;s computing capacity. Shares of Google were up on Friday after the news. - HCA Healthcare (HCA) tumbled Friday after it opted against raising its yearly profit and sales guidance even though first quarter profit beat analysts&rsquo; views, meaning it could foresee challenges later in the year. The hospital operator reaffirmed its yearly adjusted earnings forecast of $29.10 to $31.50 a share. It reported first-quarter adjusted earnings of $7.15 a share, compared to the average analyst estimate of $7.10 a share. Adjusted earnings before interest, taxes, depreciation and amortization missed estimates.

Closing Bell: Intel Eclipse Dot-Com High, Alphabet Rises, HCA Healthcare Tumbles 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a47fe147-9ad2-4aff-b129-b43601587d23/transcript

Today’s biggest winners and losers in the stock market. 

On this episode of Stock Movers: 
Intel Corp. (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it’s finally benefiting from a boom in AI spending. Revenue will be $13.8 billion to $14.8 billion in the June quarter, the company said Thursday in a statement. Analysts estimated $13 billion on average, according to data compiled by Bloomberg. The upbeat outlook suggests that Chief Executive Officer Lip-Bu Tan is making progress on a once-improbable turnaround. After lining up major investments in Intel last year — helping to strengthen the company’s balance sheet — he’s now delivering on a promise to improve operations.
Shares of Charter Communications Inc. (CHTR) fell the most ever after the company reported “underwhelming” quarterly results. One of the country’s largest home internet providers, Charter said it lost 117,000 residential customers at its flagship Spectrum internet brand in the first quarter, more than the 98,445 that analysts expected. The company also lost 51,000 cable TV customers, a dip that follows a surprise increase at the end of 2025 driven by an aggressive bundling strategy. Revenue of $13.6 billion was essentially in line with estimates but earnings per share of $9.17 came up short of forecasts for $9.52. 
Newmont (NEM) shares rallied Friday after the world’s largest gold producer reported adjusted first-quarter EPS that beat the average analyst estimate. The miner also said it plans to repurchase $6 billion in shares as the world’s largest gold producer seeks to reward investors amid an unprecedented rally in bullion prices. Newmont also said it was on track to meet previous guidance of roughly 5.3 million ounces in gold production this year, after first-quarter output met expectations of 1.3 million.

Today&rsquo;s biggest winners and losers in the stock market.&nbsp;
On this episode of Stock Movers:&nbsp;
<ul>
<li>Intel Corp. (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it&rsquo;s finally benefiting from a boom in AI spending. Revenue will be $13.8 billion to $14.8 billion in the June quarter, the company said Thursday in a statement. Analysts estimated $13 billion on average, according to data compiled by Bloomberg. The upbeat outlook suggests that Chief Executive Officer Lip-Bu Tan is making progress on a once-improbable turnaround. After lining up major investments in Intel last year &mdash; helping to strengthen the company&rsquo;s balance sheet &mdash; he&rsquo;s now delivering on a promise to improve operations.</li>
<li>Shares of Charter Communications Inc. (CHTR) fell the most ever after the company reported &ldquo;underwhelming&rdquo; quarterly results. One of the country&rsquo;s largest home internet providers, Charter said it lost 117,000 residential customers at its flagship Spectrum internet brand in the first quarter, more than the 98,445 that analysts expected. The company also lost 51,000 cable TV customers, a dip that follows a surprise increase at the end of 2025 driven by an aggressive bundling strategy. Revenue of $13.6 billion was essentially in line with estimates but earnings per share of $9.17 came up short of forecasts for $9.52.&nbsp;</li>
<li>Newmont (NEM) shares rallied Friday after the world&rsquo;s largest gold producer reported adjusted first-quarter EPS that beat the average analyst estimate. The miner also said it plans to repurchase $6 billion in shares as the world&rsquo;s largest gold producer seeks to reward investors amid an unprecedented rally in bullion prices. Newmont also said it was on track to meet previous guidance of roughly 5.3 million ounces in gold production this year, after first-quarter output met expectations of 1.3 million.</li>
</ul>

Intel Surges to Record, Charter Falls, Newmont Rises

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3ccb58b5-3d27-40ee-ae49-b436013e1f00/transcript

Novo Nordisk's Discount, Pernod Ricard Dips, Next Jitters

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips